Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Comprehensive Pharmacogenomic Testing on the Treatment of Major Depressive Disorder

NCT03228953 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03228953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03228953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Comprehensive Pharmacogenomic Testing on the Treatment of Major Depressive Disorder
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Terminated
Start date
August 1, 2017
Completion date
July 17, 2019
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder